Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-07-17

FDA Approved: IMIPRAMINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for imipramine hydrochloride by Lupin Pharmaceuticals, confirming continued approval for the generic antidepressant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Imipramine hydrochloride (Imipramine hydrochloride)

Snippet

SUPPL AP for IMIPRAMINE HYDROCHLORIDE (IMIPRAMINE HYDROCHLORIDE)